Микроповреждения миокарда при коронарной баллонной ангиопластике (обзор литературы)

коронарная баллонная ангиопластика, осложнения, прогноз, микроповреждения миокарда, маркеры повреждения

1. Hartigan P.M., Giacomini J.C., Folland E.D. et al. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine // Am. J. Cardiol. - 1998. - Vol. 82, № 12. - Р. 1445-1450.

2.

3. Boersma E., Pieper K.S., Steyerberg E.W. et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators // Circulation. - 2000. - Vol. 101, № 22. - Р. 2557-2567.

4.

5. Fox K.A., Poole-Wilson P.A., Henderson R.A. et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Randomized Intervention Trial of unstable Angina // Lancet. - 2002. - Vol. 360, № 9335. - Р. 743-751.

6.

7. Al Suwaidi J., Holmes D.R., Salam A.M., Lennon R., Berger P.B. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty // Am. Heart J. - 2004. - Vol. 147, № 5. - Р. 815-822.

8.

9. Moreno R., Fernandez C., Alfonso F. et al. Coronary stenting versus balloon angioplasty in small vessels a meta-analysis from 11 randomized studies // J. Am. Coll. Cardiol. - 2004. - Vol. 43, № 11. - Р. 1964-1972.

10.

11. Nordmann A.J., Hengstler P., Leimenstoll B.M. et al. Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease. A meta-analysis of randomized controlled trials // Eur. Heart J. - 2004. - Vol. 25, № 1. - Р. 69-80.

12.

13. Hannan E.L., Racz M., Holmes D.R. et al. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents // Circulation. - 2008. - Vol. 117, № 16. - Р. 2071-2078.

14.

15. Malenka D.J., Kaplan A.V., Lee Lucas F. et al. Outcomes following coronary stenting in the era of bare -metal vs the era of drug-eluting stents // J. Am. Med. Assoc. - 2008. - Vol. 299, № 24. - Р. 2868-2876.

16.

17. Hirshfeld J.W., Ellis S.G., Faxon D.P. et al. ACC clinical competence statement: recommendations for the assessment and maintenance of proficiency in coronary interventional procedures // J. Am. Coll. Cardiol. - 1998. - Vol. 31, № 3. - Р. 722-743.

18.

19. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention: a report of the American College of Cardiology, American Heart Association. Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) // Circulation. - 2006. - Vol. 113, № 7. - P. e166-e286.

20.

21. Applegate R.J., Sacrinty M.T., Kutcher M.A. et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007 // J. Am. Coll. Cardiol. Interv. - 2008. - Vol. 1, № 3. - Р. 317-326.

22.

23. Crenshaw B.S., Bauman R.P., Zuckerman B.D. et al. Myonecrosis after revascularization procedures // J. Am. Coll. Cardiol. - 1998. - Vol. 31, № 2. - Р. 241-251.

24.

25. Saadeddin S.M ., Habbab M.A ., Sobki S.H et al. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting // Med. Sci. Monit. - 2000. - Vol. 4, № 6. - Р. 708-712.

26.

27. Choi J.W., Gibson C.M., Murphy S.A. et al. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction // Catheter Cardiovasc. Interv. - 2004. - Vol. 61, № 4. - Р. 472-476.

28.

29. Bhatt D.L., Topol E.J. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes // Circulation. - 2005. - Vol. 112, № 6. - Р. 906-922.

30.

31. Тhygesen K., Alpert J.S., White H.D. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction // Eur. Heart J. - 2007. - Vol. 28, № 20. - Р. 2525-2538.

32.

33. Oh J.K., Shub C., Ilstrup D.M. et al. Creatine kinase release after successful percutaneous transluminal coronary angioplasty //Am. Heart J. - 1985. - Vol. 109, № 6. - Р. 1225-1231.

34.

35. Klein L.W., Kramer B.L., Howard E. et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q-wave myocardial infarction associated with coronary angioplasty // J. Am. Coll. Cardiol. - 1991. - Vol. 17, № 3. - Р. 621-626.

36.

37. Herrmann J. Peri-procedural myocardial injury: 2005 update // Eur. Heart J. - 2005. - Vol. 26, № 23. - Р. 2493-2519.

38.

39. Bonaca M., Wiviott S., Sabatine M. et al. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-Type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 Trial) // Am. J. Cardiol. - 2007. - Vol. 99, № 3. - Р. 344-348.

40.

41. Henriques J.P., Zijlstra F., Ottervanger J.P. et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction // Eur. Heart J. - 2002. - Vol. 23, № 14. - Р. 1112-1117.

42.

43. Bonderman D., Teml A., Jakowitsch J. et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque // Blood. - 2002. - Vol. 99, № 8. - Р. 2794-2800.

44.

45. Serrano C., Ramires J., Venturinelli M. et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: evidence of inflammatory responses in coronary angioplasty // J. Am. Coll. Cardiol. - 1997. - Vol. 29, № 6. - Р. 1276-1283.

46.

47. Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies // Eur. Heart J. - 2001. - Vol. 22, № 9. - Р. 729-739.

48.

49. Herrmann J., Haude M., Lerman A. et al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation // Circulation. - 2001. - Vol. 103, № 19. - Р. 2339-2345.

50.

51. Li J., Jabara R., Pendyala L. et al. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents // J. Am. Coll. Cardiol. Interv. - 2008. - Vol. 1, № 3. - Р. 279-285.

52.

53. Jeremias A., Albirini A., Ziada K.M. et al. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction // Am. Heart J. - 2002. - Vol. 143, № 6. - Р. 1040-1045.

54.

55. Gruberg L., Fuchs S., Waksman R. et al. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis // Catheter Cardiovasc. Interv. - 2002. - Vol. 55, № 2. - Р. 174-179.

56.

57. Roe M.T., Mahaffey K.W., Kilaru R. et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes // Eur. Heart J. - 2004. - Vol. 25, № 4. - Р. 313-321.

58.

59. Ryan T.J., Faxon D.D., Gunnar R.M. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology // J. Am. Coll. Cardiol. - 1988. - Vol. 12, № 2. - Р. 529.

60.

61. Ellis S.G., Vandormael M.G., Cowley M.J. et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group // Circulation. -1999. - Vol. 82, № 4. - Р. 1193-1202.

62.

63. Herold U., Piotrowski J., Jakob H. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery // Circulation. - 2006. - Vol. 114 (1 suppl.). - Р. I-441-I-447.

64.

65. Cuisset T., Hamilos M., Melikia N. et al. Direct stenting for stable angina pectoris Is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation // J. Am. Coll. Cardiol. - 2008. - Vol. 51, № 11. - Р. 1060-1065.

66.

67. Iakovou I., Mintz G.S., Dangas G. et al. Increased CK-MB release is a «trade-off» for optimal stent implantation: an intravascular ultrasound study // J. Am. Coll. Cardiol. - 2003. - Vol. 42, № 11. - Р. 1900-1905.

68.

69. Topol E.J., Leya F., Pinkerton C.A. et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group // N. Engl. J. Med. - 1993. - Vol. 329, № 4. - Р. 221-227.

70.

71. Abdelmeguid A.E., Topol E.J., Whitlow P.L. et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions // Circulation. - 1996. - Vol. 94, № 7. - Р. 1528-1536.

72.

73. Kong T.Q., Davidson C.J., Meyers S.N. et al. Prognostic implication of creatine kinase elevation following elective coronary artery interventions // J. Am. Med. Assoc. - 1997. - Vol. 277, № 6. - Р. 461-466.

74.

75. Brener S.J., Lytle B.W., Schneider J.P. et al. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality // J. Am. Coll. Cardiol. - 2002. - Vol. 40, № 11. - Р. 1961-1967.

76.

77. Ghazzal Z., Ashfaq S., Morris D.C. et al. Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era // Am. Heart J. - 2003. - Vol. 145, № 6. - Р. 1006-1012.

78.

79. Тhygesen K., Alpert J.S., White H.D. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction // Eur. Heart J. - 2007. - Vol. 28, № 20. - Р. 2525-2538.

80.

81. Karim M.A., Shinn M., Oskarsson H. et al. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty // Am. J. Cardiol. - 1995. - Vol. 76, № 7. - Р. 521-523.

82.

83. Wu A.H.B., Boden W.E., McKay R.G. Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary intervention // Circulation. - 2002. - Vol. 89, № 11. - Р. 1300-1302.

84.

85. Bonz A.W., Lengenfelder B., Strotmann J. et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR) // J. Am. Coll. Cardiol. - 2002. - Vol. 40, № 4. - Р. 662-668.

86.

87. Nallamothu B.K., Chetcuti S., Mukherjee D. et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention // Am. J. Cardiol. - 2003. - Vol. 91, № 10. - Р. 1272-1274.

88.

89. Selvanayagam J.B., Porto I., Channon K. et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging // Circulation. - 2005. - Vol. 111, № 8. - Р. 1027-1032.

90.

91. Ricciardi M.J., Wu E., Davidson C.J. et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation // Circulation. - 2001. - Vol. 103, № 23. - Р. 2780-2783.

92.

93. Choi J.W., Gibson C.M., Murphy S.A. et al. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction // Catheter Cardiovasc. Interv. - 2004. - Vol. 61, № 4. - Р. 472-476.

94.

95. Larose Е. Below radar: contributions of cardiac magnetic resonance to the understanding of myonecrosis after percutaneous coronary intervention // Circulation. - 2006. - Vol. 114, № 7. - Р. 620-622.

96.

97. Selvanayagam J.B., Jerosch-Herold M., Porto I. et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment // Circulation. - 2005. - Vol. 112, № 21. - Р. 3289-3296.

98.

99. Redwood S.R., Popma J.J., Kent K.M. «Minor» CK-MB elevations are associated with increased late mortality following ablative new-device angioplasty in native coronary arteries (Abstr.) // Circulation. - 1995. - Vol. 92, № 3. - Р. I-544.

100.

101. Kini A.S., Lee P., Marmur J.D. et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality // Am. J. Cardiol. - 2004. - Vol. 93. - Р. 18-23.

102.

103. Cavallinin C., Savonitto S., Violini R. et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study // Eur. Heart J. - 2005. - Vol. 26, № 15. - Р. 1494-1498.

104.

105. Cantor W.J., Newby L.K., Christenson R.H. et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention // J. Am. Coll. Cardiol. - 2002. - Vol. 39, № 11. - Р. 1738-1744.

106.

107. Kleiman N.S. Measuring troponin elevation after percutaneous coronary intervention: Ready for prime time? // J. Am. Coll. Cardiol. - 2006. - Vol. 48, № 9. - Р. 1771-1773.

108.

109. Bertinchant J.P., Polge A., Ledermann B. et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris // Am. J. Cardiol. - 1999. - Vol. 84, № 1. - Р. 51-57.

110.

111. Garbarz E., Iung B., Lefevre G. et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting // Am. J. Cardiol. - 1999. - Vol. 84, № 5. - Р. 515-518.

112.

113. Wu A.H.B., Boden W.E., McKay R.G. Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary intervention // Circulation. - 2002. - Vol. 89, № 11. - Р. 1300-1302.

114.

115. Nageh T., Sherwood R.A., Thomas M.R. Prognostic implications of cardiac marker elevation after percutaneous coronary intervention // Circulation. - 2002. - Vol. 105, № 1. - Р. 73. <http://eurheartj.oxfordjournals.org/cgi/ijlink?linkType=FULL&journalCode=circulationaha&resid=105/12/e73>

116.

117. Harrington R.A., Lincoff A.M., Califf R.M.. et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT) // J. Am. Coll. Cardiol. - 1995. - Vol. 25, № 7. - Р. 1693-1699.

118.

119. Abdelmeguid A.E., Ellis S.G., Sapp S.K. et al. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions // Am. Heart J. - 1996. - Vol. 131, № 6. - Р. 1097-1105.

120.

121. Stone G.W., Mehran R., Dangas G. et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients // Circulation. - 2001. - Vol. 104, № 6. - Р. 642-647.

122.

123. Hong M.K., Mehran R., Dangas G. et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality // Circulation. -1999. - Vol. 100, № 24. - Р. 2400-2405.

124.

125. Akkerhuis K.M., Alexander J.H., Tardiff B.E. et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? // Circulation. -2002. - Vol. 105, № 5. - Р. 554-556.

126.

127. Jeremias A., Baim D.S., Ho K.K., et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures // J. Am. Coll. Cardiol. - 2004. - Vol. 44, № 6. - Р. 1210-1214.

128.

129. Abdelmeguid A.E., Topol E.J. The myth of the myocardial «infarctlet» during percutaneous coronary revascularization // Circulation. - 1996. - Vol. 94, № 12. - Р. 3369-3375.

130.

131. Holmes D.R., Berger P.B. Troponisms, necrosettes, enzyme leaks, creatine phosphokinase bumps, and infarctlets // Circulation. - 2001. - Vol. 104, № 6. - Р. 627-629.

132.

133. Cutlip D.E., Kuntz R.E. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes // Circulation. - 2005. - Vol. 112, № 6. - Р. 916-922.

134.

135. Heeschen C., Goldmann B.U., Terres W. et al. Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to troponin T status // Eur. Heart J. - 2000. - Vol. 21, № 14. - Р. 1159-1166.

136.

137. Lindahl B., Toss H., Siegbahn A. et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease // N. Engl. J. Med. - 2000. - Vol. 343, № 16. - Р. 1139-1147.

138.

139. Mulvihill N.T., Foley J.B. Inflammation in acute coronary syndromes // Heart. - 2002. -Vol. 87, № 3. - Р. 201-204.

140.

141. Heeschen C., Hamm C.W., Bruemmer J., Simoons M.L. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial // J. Am. Coll. Cardiol. - 2000. - Vol. 35, № 6. - Р. 1535-1542.

142.

143. Toss H., Lindahl B., Siegbahn A., Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease // Circulation. - 1997. - Vol. 96, № 12. - Р. 4204-4210.

144.

145. Morrow D.A., Rifai N., Antman E.M. et al. C-reactive protein I a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction // J. Am. Coll. Cardiol. - 1998. - Vol. 31, № 7. - Р. 1460-1465.

146.

147. Leu H.B., Lin C.P., Lin W.T. et al. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein // Chest. - 2004. - Vol. 126, № 4. - Р. 1032-1039.

148.

149. Gottsauner-Wolf M., Zasmeta G., Hornykewycz S. et al. Plasma levels of C-reactive protein after coronary stent implantation // Eur. Heart J. - 2000. - Vol. 21, № 14. - Р. 1152-1158.

150.

151. Sanchez-Margalet V., Cubero J.M., Martin-Romero C. et al. Inflammatory response to coronary stent implantation in patients with unstable angina // Clin. Chem. Lab. Med. - 2002. - Vol. 40, № 8. - Р. 769-774.

152.

153. Bonz A.W., Lengenfelder B., Jacobs M. et al. Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism // Am. Heart J. - 2003. - Vol. 145, № 4. - Р. 693-699.

154.

155. Gaspardone A., Crea F., Versaci F. et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina // Am. J. Cardiol. - 1998. - Vol. 82, № 4. - Р. 515-518.

156.

157. Inoue T., Sohma R., Miyazaki T., Iwasaki Y., Yaguchi I., Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris // Am. J. Cardiol. - 2000. - Vol. 86, № 10. - Р. 1057-1062.

158.

159. Serrano C.V. Jr, Ramires J.A., Venturinelli M. et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: evidence of inflammatory responses in coronary angioplasty // J. Am. Coll. Cardiol. - 1997. - Vol. 29, № 6. - Р. 1276-1283.

160.

161. Azar R.R., Aoun G., Fram D.B. et al. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests // Am. J. Cardiol. - 2000. - Vol. 86, № 2. - Р. 205-207.

162.

163. Arroyo-Espliguero R., Avanzas P., Cosın-Sales J. et al. C-reactive protein elevation and disease activity in patients with coronary artery disease // Eur. Heart J. - 2004. - Vol. 25, № 5. - Р. 401-408.

164.

165. Goldberg A., Gruberg L., Roguin A. et al. Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with Stable Angina // Am. Heart J. - 2006. - Vol. 151, № 6. - Р. 1265-1270.

166.

167. Haverkate F., Thompson S.G., Pyke S.D. et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group // Lancet. - 1997. - Vol. 349, № 9050. - Р. 462-466.

168.

169. Zebrack J.S., Muhlestein J.B., Horne B.D. et al. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina // J. Am. Coll. Cardiol. - 2002. - Vol. 39, № 4. - Р. 632-637.

170.

171. Saadeddin S.M., Habbab M.A., Sobki S.H., Ferns G.A. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention // Am. J. Cardiol. - 2002. - Vol. 89, № 8. - Р. 981-983.

172.

173. Park D.W., Lee C.W., Yun S.C. et al. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation // Heart. - 2007. - Vol. 93, № 9. - Р. 1087-1092.

174.

175. Gomes W. J., Buffolo E. Coronary stenting and inflammation: implications for further surgical and medical treatment // Ann. Thorac. Surg. - 2006. - Vol. 81, № 5. - Р. 1918-1925.

176.

177. Saleh N., Svane B., Hansson L.O. et al. Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value // Clin. Chem. - 2005. - Vol. 51, № 11. - Р. 2124 - 2130.

178.

179. Makrygiannis S.S., Beldekos D.J., Devoe M.C. et al. Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and longterm prognosis after successful coronary stenting (four-year results from the GENERATION study) // Am. J. Cardiol. - 2005. - Vol. 95, № 3. - Р. 386-390.

180.

181. Gurm H.S., Bhatt D.L., Gupta R., Ellis S.G., Topol E.J., Lauer M.S. Preprocedural white blood cell count and death after percutaneous coronary intervention // Am. Heart J. - 2003. - Vol. 146, № 4. - Р. 692-698.

182.

183. Bhatt D.L., Topol E.J. Need to test the arterial inflammation hypothesis // Circulation. - 2002. - Vol. 106, № 1. - Р. 136-140.

184.

185. Walter J.G., Buffolo E. Coronary stenting and inflammation: implication for further surgical and medical treatment // Ann. Thorac. Surg. - 2006. - Vol. 81. - Р. 1918-1925.